FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN
Delisted
FUSN was delisted on the 3rd of June, 2024.
114 hedge funds and large institutions have $1.47B invested in Fusion Pharmaceuticals Inc. Common Shares in 2024 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% more funds holding
Funds holding: 77 → 114 (+37)
43% less call options, than puts
Call options by funds: $48M | Put options by funds: $84.2M
Holders
114
Holding in Top 10
8
Calls
$48M
Puts
$84.2M
Top Buyers
| 1 | +$89.3M | |
| 2 | +$86.9M | |
| 3 | +$80.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$25.2M |
| 5 |
Millennium Management
New York
|
+$22M |
Top Sellers
| 1 | -$74.1M | |
| 2 | -$30M | |
| 3 | -$28.3M | |
| 4 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$21.3M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$13.6M |
